Impact of EGFR Mutation on Prognosis of Stage IV Non-Squamous Non-Small Cell Lung Cancer NSCLC: A Retrospective Analysis
Background: Patients with activating somatic mutations in the Epidermal Growth Factor Receptor (EGFR) have better prognosis when treated with Tyrosine Kinase Inhibitors (TKI) as the standard treatment of care in this group of patients.Aim of the work: To study the impact of EGFR mutation on prognosi...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Ain Shams University; Faculty of Medicine. Ain Shams Clinical and Scientific Society
2023-06-01
|
| Cyfres: | Ain Shams Medical Journal |
| Pynciau: | |
| Mynediad Ar-lein: | https://asmj.journals.ekb.eg/article_383254.html |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|